David W. Essex

Dr. David W. Essex


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2015 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
JZJunsong Zhou
Junsong Zhou
YWYi Wu
Yi Wu
LWLu Wang
Lu Wang
LRLubica Rauova
Lubica Rauova
VHVincent M. Hayes
Vincent M. Hayes
DEDavid W. Essex
David W. Essex
Protein disulfide isomerase (PDI) has two distinct CGHC redox-active sites; however, the contribution of these sites during different physiologic reactions, including thrombosis, is unknown. Here, we evaluated the role of PDI and redox-active sites of PDI in thrombosis by generating mice with blood cells and vessel wall cells lacking PDI (Mx1-Cre Pdifl/fl mice) and transgenic mice harboring PDI that lacks a functional C-terminal CGHC motif [PDI(ss-oo) mice]. Both mouse models showed decreased fibrin deposition and platelet accumulation in laser-induced cremaster arteriole injury, and PDI(ss-oo) mice had attenuated platelet accumulation in FeCl3-induced mesenteric arterial injury. These defects were rescued by infusion of recombinant PDI containing only a functional C-terminal CGHC motif [PDI(oo-ss)]. PDI infusion restored fibrin formation, but not platelet accumulation, in eptifibatide-treated wild-type mice, suggesting a direct role of PDI in coagulation. In vitro aggregation of platelets from PDI(ss-oo) mice and PDI-null platelets was reduced; however, this defect was rescued by recombinant PDI(oo-ss). In human platelets, recombinant PDI(ss-oo) inhibited aggregation, while recombinant PDI(oo-ss) potentiated aggregation. Platelet secretion assays demonstrated that the C-terminal CGHC motif of PDI is important for P-selectin expression and ATP secretion through a non-αIIbβ3 substrate. In summary, our results indicate that the C-terminal CGHC motif of PDI is important for platelet function and coagulation.

1 May 2009 in Antioxidants & Redox Signaling
Verified
Journal Article
Closed access
DEDavid W. Essex
David W. Essex
There has recently been a dramatic expansion in research in the area of redox biology with systems that utilize thiols to perform redox chemistry being central to redox control. Thiol-based reactions occur in proteins involved in platelet function, including extracellular platelet proteins. The alphaIIbbeta3 fibrinogen receptor contains free thiols that are required for the activation of this receptor to a fibrinogen-binding conformation. This process is under enzymatic control, with protein disulfide isomerase playing a central role in the activation of alphaIIbbeta3. Other integrins, such as the alpha2beta1 collagen receptor on platelets, are also regulated by protein disulfide isomerase and thiol metabolism. Low molecular weight thiols that are found in blood regulate these processes by converting redox sensitive disulfide bonds to thiols and by providing the appropriate redox potential for these reactions. Additional mechanisms of redox control of platelets involve nitric oxide that inhibits platelet responses, and reactive oxygen species that potentiate platelet thrombus formation. Specific nitrosative or oxidative modifications of thiol groups in platelets may modulate platelet function. Since many biologic processes are regulated by redox reactions that involve surface thiols, the extracellular redox state can have an important influence on health and disease status and may be a target for therapeutic intervention.

16 February 2012 in Blood
Verified
Journal Article
Open access
PDF file
YWYi Wu
Yi Wu
SASyed S. Ahmad
Syed S. Ahmad
JZJunsong Zhou
Junsong Zhou
LWLu Wang
Lu Wang
MCMatthew P. Cully
Matthew P. Cully
DEDavid W. Essex
David W. Essex
A close homologue to protein disulfide isomerase (PDI) called ERp57 forms disulfide bonds in glycoproteins in the endoplasmic reticulum and is expressed on the platelet surface. We generated 2 rabbit Abs to ERp57. One Ab strongly inhibited ERp57 in a functional assay and strongly inhibited platelet aggregation. There was minimal cross-reactivity of this Ab with PDI by Western blot or in the functional assay. This Ab substantially inhibited activation of the αIIbβ3 fibrinogen receptor and P-selectin expression. Furthermore, adding ERp57 to platelets potentiated aggregation. In contrast, adding a catalytically inactive ERp57 inhibited platelet aggregation. When infused into mice the inactive ERp57 prolonged the tail bleeding times. We generated 2 IgG2a mAbs that reacted with ERp57 by immunoblot. One of these Abs inhibited both ERp57 activity and platelet aggregation. The other Ab did not inhibit ERp57 activity or platelet aggregation. The inhibitory Ab inhibited activation of αIIbβ3 and P-selectin expression, prolonged tail bleeding times, and inhibited FeCl3-induced thrombosis in mice. Finally, we found that a commonly used mAb to PDI also inhibited ERp57 activity. We conclude that a glycoprotein-specific member of the PDI family, ERp57, is required for platelet aggregation, hemostasis, and thrombosis.

21 November 2013 in Blood
Verified
Journal Article
Open access
PDF file
LWLu Wang
Lu Wang
YWYi Wu
Yi Wu
JZJunsong Zhou
Junsong Zhou
SASyed S. Ahmad
Syed S. Ahmad
BMBulent Mutus
Bulent Mutus
DEDavid W. Essex
David W. Essex
Key Points: Platelet-derived ERp57 plays an important role in physiologic platelet function and thrombosis. ERp57 directly interacts with αIIbβ3 in regulating its function.

10 August 2017 in Blood
Verified
Journal Article
Open access
PDF file
JZJunsong Zhou
Junsong Zhou
YWYi Wu
Yi Wu
FCFengwu Chen
Fengwu Chen
LWLu Wang
Lu Wang
LRLubica Rauova
Lubica Rauova
DEDavid W. Essex
David W. Essex
Key Points: Intravascular ERp72 supports platelet accumulation and fibrin generation through the a and a′ active sites. ERp72 functions separately from protein disulfide isomerase and ERp57 in supporting platelet aggregation.

17 January 2019 in Blood
Verified
Journal Article
Closed access
PDF file
ZZZhenzhen Zhao
Zhenzhen Zhao
YWYi Wu
Yi Wu
JZJunsong Zhou
Junsong Zhou
FCFengwu Chen
Fengwu Chen
AYAizhen Yang
Aizhen Yang
DEDavid W. Essex
David W. Essex
Secreted platelet protein disulfide isomerases, PDI, ERp57, ERp5 and ERp72, have important roles as positive regulators of platelet function and thrombosis. Thioredoxin-related transmembrane protein 1 (TMX1) was the first described transmembrane member of the protein disulfide isomerase family of enzymes. Using a specific antibody, recombinant TMX1 protein (rTMX1), a knockout mouse model, and thiol-labeling approach, we examined the role of TMX1 in platelet function and thrombosis. Expression of TMX1 on the platelet surface increased with thrombin stimulation. The anti-TMX1 antibody increased platelet aggregation induced by convulxin and thrombin, and potentiated platelet ATP release. In contrast, rTMX1 inhibited platelet aggregation and ATP release. TMX1-deficient platelets had increased aggregation, ATP release, αIIbβ3 activation, and P-selectin expression, which were reversed by addition of rTMX1. TMX1-knockout mice had increased incorporation of platelets into a growing thrombus in a FeCl3-induced mesenteric arterial injury, and shortened tail-bleeding times. rTMX1 oxidized thiols in the αIIbβ3 integrin and TMX1-deficient platelets had increased thiols in the β3 subunit of αIIbβ3, consistent with oxidase activity of rTMX1 against αIIbβ3. Thus, TMX1 is the first identified extracellular inhibitor of platelet function and the first disulfide isomerase that negatively regulates platelet function. Key points Extracellular TMX1 negatively regulates activation of the αIIbβ3 integrin and platelet aggregation.